| 词条 | N1-Methyl-lysergic acid diethylamide |
| 释义 |
| Watchedfields = changed | verifiedrevid = 447572878 | IUPAC_name = (8β)-N,N-Diethyl-1,6-dimethyl-9,10-didehydroergoline-8-carboxamide | image = MLD-41.svg | tradename = | legal_AU = | legal_CA = | legal_UK = | legal_US = | routes_of_administration = Oral | metabolism = hepatic | excretion = renal | CAS_number_Ref = {{cascite|correct|??}} | CAS_number = 4238-85-1 | PubChem = 165200 | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID = 144824 | C=21 | H=27 | N=3 | O=1 | molecular_weight = 337.47 g/mol | smiles = O=C(N(CC)CC)[C@@H]3/C=C2/c4cccc1c4c(cn1C)C[C@H]2N(C3)C | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C21H27N3O/c1-5-24(6-2)21(25)15-10-17-16-8-7-9-18-20(16)14(12-22(18)3)11-19(17)23(4)13-15/h7-10,12,15,19H,5-6,11,13H2,1-4H3/t15-,19-/m1/s1 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = VQZYKSWQIQANKB-DNVCBOLYSA-N | synonyms = MLD-41, N1- Methyl- Lysergic Acid Diethylamide }} N1-Methyl-lysergic acid diethylamide (MLD-41) is a derivative of LSD. Metabolism of other 1-methylated-ergoloids to their secondary amine derivatives has been frequently noted in mammals.[1] References1. ^Müller-Schweinitzer and Tapparelli (1986). Methylergometrine, an active metabolite of methysergide. Cephalalgia. 6: 35-41. {{Hallucinogenic lysergamides}}{{DEFAULTSORT:Mld-41}}{{hallucinogen-stub}} 1 : Lysergamides |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。